Galmed Pharmaceuticals Ltd. buy Piper Sandler
Start price
06.11.24
/
50%
€6.40
Target price
06.11.25
€93.31
Performance (%)
-
End price
07.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Piper_Sandler for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Piper Sandler from $80.00 to $100.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
09.05.25
09.05.25
€71.34
09.05.26
09.05.26
-
19.09.24
19.09.24
Stopped prediction by Piper_Sandler for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.37
20.05.24
20.05.24
€73.65
20.05.25
20.05.25
1648.63%
21.05.25
21.05.25